Procter & Gamble (NYSE:PG) Trading 1.1% Higher – Here’s Why

Procter & Gamble Company (The) (NYSE:PGGet Free Report)’s share price shot up 1.1% on Tuesday . The stock traded as high as $145.90 and last traded at $144.9660. 7,348,882 shares changed hands during mid-day trading, a decline of 32% from the average session volume of 10,818,635 shares. The stock had previously closed at $143.42.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Reported earnings slightly above expectations and set FY2026 guidance (management sees EPS 6.83–7.09), supporting confidence in profit trajectory despite mixed top-line signals.
  • Positive Sentiment: Olay launched a major “Skinsurance” campaign around its clinically backed Super Collection, a brand push intended to drive skincare premiumization and long-term category growth. Olay Skinsurance press release
  • Neutral Sentiment: Analyst target-price coverage is being refreshed across outlets, keeping PG front of mind for income and defensive-growth investors but producing no clear consensus catalyst. Analyst target-price roundup
  • Neutral Sentiment: Pantene introduced a seasonal leave-in protection spray and Metamucil launched a digital content series—marketing initiatives that can modestly support category share and e-commerce engagement but are unlikely to move near-term results materially. Pantene launch Metamucil campaign
  • Neutral Sentiment: Coverage noting PG in valuation/portfolio screens (e.g., “Dogs of the Dow” commentary and valuation rechecks) highlights investor interest in PG’s income and defensive attributes but does not imply immediate directional pressure. Dogs of the Dow article Valuation recheck
  • Negative Sentiment: Analyses flag weak consumer volumes in several categories; while management is offsetting cost pressure with productivity and supply-chain moves, sustained volume weakness could limit top-line growth and cap multiple expansion. Cost-discipline vs. weak volumes analysis

Wall Street Analyst Weigh In

Several brokerages have weighed in on PG. Royal Bank Of Canada dropped their price objective on shares of Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating for the company in a research note on Thursday, April 9th. Raymond James Financial dropped their price objective on shares of Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating for the company in a research note on Tuesday, April 14th. JPMorgan Chase & Co. dropped their price objective on shares of Procter & Gamble from $165.00 to $162.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Barclays dropped their price objective on shares of Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. Finally, BNP Paribas Exane dropped their target price on shares of Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating for the company in a research report on Thursday, April 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $161.06.

Check Out Our Latest Research Report on PG

Procter & Gamble Stock Up 1.1%

The firm’s 50-day moving average price is $149.44 and its 200 day moving average price is $148.62. The company has a market capitalization of $337.57 billion, a price-to-earnings ratio of 21.19, a PEG ratio of 6.31 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.56 by $0.03. The company had revenue of $21.24 billion during the quarter, compared to analysts’ expectations of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts forecast that Procter & Gamble Company will post 6.92 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 24th will be issued a dividend of $1.0885 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. Procter & Gamble’s payout ratio is presently 63.60%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,827 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the sale, the insider owned 12,639 shares of the company’s stock, valued at approximately $2,026,158.09. The trade was a 50.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the business’s stock in a transaction on Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the sale, the insider directly owned 44,735 shares in the company, valued at approximately $7,259,595.80. The trade was a 25.32% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 252,715 shares of company stock worth $40,966,904 over the last 90 days. 0.20% of the stock is owned by corporate insiders.

Institutional Trading of Procter & Gamble

A number of hedge funds and other institutional investors have recently modified their holdings of PG. Norges Bank bought a new stake in shares of Procter & Gamble during the fourth quarter worth $4,664,783,000. Cardano Risk Management B.V. grew its stake in shares of Procter & Gamble by 1,104.8% during the fourth quarter. Cardano Risk Management B.V. now owns 9,521,440 shares of the company’s stock worth $1,364,518,000 after buying an additional 8,731,126 shares during the last quarter. Auto Owners Insurance Co grew its stake in shares of Procter & Gamble by 14,231.0% during the fourth quarter. Auto Owners Insurance Co now owns 3,549,645 shares of the company’s stock worth $508,700,000 after buying an additional 3,524,876 shares during the last quarter. Vanguard Group Inc. grew its holdings in Procter & Gamble by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock worth $34,030,358,000 after acquiring an additional 2,829,151 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in Procter & Gamble by 100.8% during the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company’s stock worth $782,607,000 after acquiring an additional 2,741,924 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

(Get Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Further Reading

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.